January 2023 PMID 36741761

Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies.

Kexue Liang, Hongzhen Luo, Qi Li

Download social card

Mentions

12
Peak: 4 in Nov 2025
across 3 sources since Jan 2023

Extended reach

4,982
potential audience

Total likes

4

Video views

680

Mentions per month

Jan 2023 – Dec 2025

Where it's discussed

  • YouTube8 videos
  • X / Twitter3 posts
  • News1 articles

AI synopsis

What people are saying

Posts express a general agreement with the publication's findings, noting the critical role of perfusion media in maintaining high cell densities and emphasizing the study's contribution to biotech advancements. The tone suggests a keen interest in practical applications, with phrases like 'optimized strategies' and 'scaling up,' indicating recognition of the study's significance for large-scale production.

AgreementModerate agreement

Most posts show support or recognition of the research's importance, highlighting its relevance to ongoing developments in biotech.

InterestModerate interest

Discussions demonstrate some level of curiosity, focusing on the significance of perfusion strategies for antibody production.

EngagementModerate engagement

Posts include specific references to concepts like cell culture and bioprocessing, indicating a moderate level of engagement.

ImpactModerate impact

Participants acknowledge the potential of the research to influence monoclonal antibody production techniques.

Abstract in brief

  • The study shows that continuous perfusion culture strategies, especially with optimized rates and delayed temperature reduction, can improve the stability, cell density, and quality of monoclonal antibody production in CHO cells compared to intermittent perfusion.
  • Adjusting perfusion rates and temperature at strategic times (e.g., delaying temperature reduction to day 6) significantly increases product yield, with the highest titer reaching 16.19 g/L and maintaining good product quality.
  • These optimized methods were successfully scaled up to a 200L bioreactor, achieving a peak titer of 16.79 g/L on day 16 while preserving product quality, offering useful guidance for efficient large-scale monoclonal antibody production.

Top posts

Most liked on X and Bluesky
Frontiers - Bioengineering and Biotechnology
@FrontBioeng · X

New Research: Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies https://t.co/C8YAr3ZdaB #bioengineering #biotech

Jan 20, 2023 · 3,921 followers View post →
Aspen Media
@aspen_media_inc · X

The perfusion medium is critical in maintaining high cell concentration in cultures for the production of monoclonal antibody by Chinese hamster ovary cells. Learn More: https://t.co/3hJvhN2EPH #aspenalert #biotechnology https://t.co/vwGi8w8pSr

Jun 14, 2023 · 311 followers View post →

All mentions

CHO Cell Papers
@CHOculturePaper · X

Sep 17, 2025 · 62 followers View post →
Aspen Media
@aspen_media_inc · X

The perfusion medium is critical in maintaining high cell concentration in cultures for the production of monoclonal antibody by Chinese hamster ovary cells. Learn More: https://t.co/3hJvhN2EPH #aspenalert #biotechnology https://t.co/vwGi8w8pSr

Jun 14, 2023 · 311 followers View post →
Frontiers - Bioengineering and Biotechnology
@FrontBioeng · X

New Research: Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies https://t.co/C8YAr3ZdaB #bioengineering #biotech

Jan 20, 2023 · 3,921 followers View post →
CHO细胞灌流工艺缩小模型的开发策略|反应器|培养基|开发策略|灌流 ...
News

DOI:10.3389/fbioe.2023.1112349. [2] Perfusion Cell Culture Processes for Biopharmaceuticals Process Development, Design, and Scale-up. 关于赛 ...

Jun 12, 2025 View →